Base-Edited Hematopoietic Stem/Progenitor Cell Gene Therapy for Treatment of CXCR4-WHIM | MicrobiomeTrials← Back to trialsNCT07775313
Base-Edited Hematopoietic Stem/Progenitor Cell Gene Therapy for Treatment of CXCR4-WHIM
RecruitingPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2026-09-16Est. Completion: 2031-12-31
Enrollment target: 10 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
Waldenström's MacroglobulinemiaChronic Lymphocytic LeukemiaMarginal Zone LymphomaFollicular Lymphoma
The objective of this NIS is to evaluate medical resource utilization, where data is rare in all cohorts, patient's QoL …
Salzburg, AustriaEst. completion Aug 2028
LeukopeniaNeutropeniaInfectionsWartsMyelokathexis
Background:
* WHIMS (Warts, Hypogammaglobulinemia, Infections, and Myelokathexis Syndrome) is caused by various genetic…
Bethesda, United StatesCompleted Aug 6, 2026